Lurasidone Hydrochloride

Spécifications

367514-88-3Numéro CAS

682-423-6Numéro CE

(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione;hydrochlorideNom IUPAC

C28H37ClN4O2SFormule chimique

529.1 g/molMasse molaire

Lurasidone hydrochloride; 367514-88-3; Lurasidone HCl; SM-13496; SM 13496; O0P4I5851I; CHEBI:70732; DTXSID401027714; 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(((1R,2R)-2-((4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)methyl)cyclohexyl)methyl)hexahydro-, monohydrochloride, (3aR,4S,7R,7aS)-; SM13496; HCl, Lurasidone; 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, monohydrochloride, (3aR,4S,7R,7aS)-; RefChem:57130; Hydrochloride, Lurasidone; DTXCID701513291; SM13,496; 13496, SM; SM 13,496; SM-13,496; 682-423-6; Latuda; Lurasidonhydrochloride; exo-cis-Lurasidone Hydrochloride; Lurasidone hydrochloride [USAN]; (1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione;hydrochloride; Lurasidone-d8 Hydrochloride; (3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione hydrochloride; (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione monohydrochloride; 139563-25-0; Trans Lurasidone Hydrochloride; C28H37ClN4O2S; UNII-O0P4I5851I; Lurasidone HCl?; Latuda (TN); lurasidone monohydrochloride; Latuda, SM 13496; orb1225185; orb1307576; SCHEMBL1534132; SM-13496 HCl; CHEMBL1615372; SCHEMBL29354704; HY-B0032R; NEKCRUIRPWNMLK-SCIYSFAVSA-N; GLXC-90409; EBC-28061; Lurasidone hydrochloride (JAN/USAN); LURASIDONE HYDROCHLORIDE [MI]; MFCD18917095; s3044; SMP-13496; LURASIDONE HYDROCHLORIDE [JAN]; AKOS022185856; Lurasidone (Hydrochloride) (Standard); EX-3125; FL24958; MK-3756; LURASIDONE HYDROCHLORIDE [MART.]; LURASIDONE HYDROCHLORIDE [VANDF]; LURASIDONE HYDROCHLORIDE [WHO-DD]; 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, hydrochloride (1:1), (3aR,4S,7R,7aS)-; AS-35074; Lurasidone hydrochloride, >=98% (HPLC); LURASIDONE HYDROCHLORIDE [ORANGE BOOK]; D04820; EN300-7409921; Q27882070; Z3241270511; (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl]-1-cyclohexylmethyl]-2,3-bicyclo[2.2.1]heptanedicarboxyimide hydrochloride; (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0,2,6]decane-3,5-dione hydrochloride; (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0^{2,6}]decane-3,5-dione hydrochloride; (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindol e-1,3(2H)-dione hydrochloride; (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; (3aR,4S,7R,7aS)-2-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione hydrochloride; 4-(1,2-benzothiazol-3-yl)-1-{[(1R,2R)-2-{[(3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]methyl}cyclohexyl]methyl}piperazin-1-ium chlorideSynonymes